. "1"^^ . "EBV; recombinant protein; p18; immunoglobulin"@en . . "realiz\u00E1tor VIDIA spol. s r.o., I\u010C 16556267" . . . "Recombinant capsid protein p18 (EBC) of Epstein Barr Virus and a recombinant protein containing carboxy terminal half of p18 in a tandem repetition (2EBK), and technology of production thereof"@en . . "Recombinant capsid protein p18 (EBC) of Epstein Barr Virus and a recombinant protein containing carboxy terminal half of p18 in a tandem repetition (2EBK), and technology of production thereof"@en . "694367" . "1"^^ . "p\u0159\u00EDjmy z realizace prodeje v \u010D\u00E1stk\u00E1ch milion\u016F K\u010D" . . "p18 (EBC) , p18 (2EBK)" . "Rekombinantn\u00ED kapsidov\u00FD protein p18 (EBC) viru Epsteina a Barrov\u00E9 a rekombinantn\u00ED protein obsahuj\u00EDc\u00ED tandemovou repetici C-koncov\u00E9 poloviny p18 (2EBK) a technologie jejich produkce"@cs . . "RIV/68378050:_____/01:00083138!RIV07-MSM-68378050" . "Rekombinantn\u00ED kapsidov\u00FD protein p18 (EBC) viru Epsteina a Barrov\u00E9 a rekombinantn\u00ED protein obsahuj\u00EDc\u00ED tandemovou repetici C-koncov\u00E9 poloviny p18 (2EBK) a technologie jejich produkce"@cs . . . "At the Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, plasmids of expression of two prototype recombinant proteins derived from the capsid protein of Epstein Barr Virus were constructed using molecular cloning methods, and the technology of their recombinant expression and purification was optimized. Samples of the prototype proteins, expression plasmids and protocols of the production technology were transferred from the Institute of Molecular Genetics to company VIDIA spol. s r.o. on the basis of a contract concluded between these two participants of the grant project LN00B030."@en . "Rekombinantn\u00ED kapsidov\u00FD protein p18 (EBC) viru Epsteina a Barrov\u00E9 a rekombinantn\u00ED protein obsahuj\u00EDc\u00ED tandemovou repetici C-koncov\u00E9 poloviny p18 (2EBK) a technologie jejich produkce" . . "Sedl\u00E1\u010Dek, Juraj" . "P(LN00B030), Z(AV0Z5052915)" . "Dv\u011B prototypov\u00E9 rekombinantn\u00ED b\u00EDlkoviny EB viru a zp\u016Fsob jejich produkce rekombinantn\u00ED expres\u00ED vedouc\u00ED k produkt\u016Fm ur\u010Den\u00FDm k pou\u017Eit\u00ED v komer\u010Dn\u00EDch klinick\u00FDch diagnostick\u00FDch souprav\u00E1ch ke stanovov\u00E1n\u00ED hladin protil\u00E1tek IgA, IgG a IgM p\u0159i infekci EBV" . . . . . "Na \u00DAstavu molekul\u00E1rn\u00ED genetiky AV \u010CR byly molekul\u00E1rn\u00EDm klonov\u00E1n\u00EDm sestaveny plasmidy exprese dvou prototypov\u00FDch rekombinantn\u00EDch b\u00EDlkovin odvozen\u00FDch od kapsidov\u00E9 b\u00EDlkoviny viru Epsteina a Barrov\u00E9 a optimalizov\u00E1ny technologie jejich rekombinantn\u00ED exprese a purifikace. Prototypy, plasmidy exprese a protokoly technologick\u00E9ho postupu byly \u00DAstavem molekul\u00E1rn\u00ED genetiky AV \u010CR p\u0159ed\u00E1ny spole\u010Dnosti VIDIA spol. s r.o. na z\u00E1klad\u011B smlouvy mezi t\u011Bmito dv\u011Bma spolu\u0159e\u0161iteli grantov\u00E9ho projektu LN00B030." . "RIV/68378050:_____/01:00083138" . . "Na \u00DAstavu molekul\u00E1rn\u00ED genetiky AV \u010CR byly molekul\u00E1rn\u00EDm klonov\u00E1n\u00EDm sestaveny plasmidy exprese dvou prototypov\u00FDch rekombinantn\u00EDch b\u00EDlkovin odvozen\u00FDch od kapsidov\u00E9 b\u00EDlkoviny viru Epsteina a Barrov\u00E9 a optimalizov\u00E1ny technologie jejich rekombinantn\u00ED exprese a purifikace. Prototypy, plasmidy exprese a protokoly technologick\u00E9ho postupu byly \u00DAstavem molekul\u00E1rn\u00ED genetiky AV \u010CR p\u0159ed\u00E1ny spole\u010Dnosti VIDIA spol. s r.o. na z\u00E1klad\u011B smlouvy mezi t\u011Bmito dv\u011Bma spolu\u0159e\u0161iteli grantov\u00E9ho projektu LN00B030."@cs . . . . . . "[7DC6622EF011]" . . . "Rekombinantn\u00ED kapsidov\u00FD protein p18 (EBC) viru Epsteina a Barrov\u00E9 a rekombinantn\u00ED protein obsahuj\u00EDc\u00ED tandemovou repetici C-koncov\u00E9 poloviny p18 (2EBK) a technologie jejich produkce" .